Cited by 417Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction ResearchHealth Promotion and Cardiovascular Prevention

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

A Test in Context

Open access

Ridker, Paul M·2016·Journal of the American College of Cardiology

DOI 10.1016/j.jacc.2015.11.037

Open this paper in CoChat — free account Open PDF

Abstract

The inflammatory biomarker high-sensitivity C-reactive protein (hsCRP) adds prognostic information on cardiovascular risk comparable to blood pressure or cholesterol. Values <1, 1 to 3, and >3 mg/l indicate lower, average, or higher relative cardiovascular risk, respectively. Global risk algorithms that include hsCRP outperform those solely using Framingham covariates. Although diet, exercise, and smoking cessation are first steps for patients with a proinflammatory response, JUPITER (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) trial data demonstrate that statins reduce by 47% the rate of first myocardial infarction, stroke, or confirmed cardiovascular death when given to patients with low-density lipoprotein-C levels of <130 mg/dl and hsCRP of >2 mg/l (hazard ratio: 0.53; 95% confidence interval: 0.40 to 0.69; p < 0.00001). In current U.S. guidelines, hsCRP carries a class IIb assessment and is most appropriate in primary prevention when clinical decisions to initiate statin therapy are uncertain. Ongoing multinational trials are pursuing whether reducing inflammation will decrease vascular event rates.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2015.11.037

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Self-citation
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Self-citation
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Self-citation
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Cannon, C. P., Blazing, M. A., Giugliano, R. P., McCagg, A., White, J. A., Theroux, P., Darius, H., Lewis, B. S., Ophuis, T. O., Jukema, J. W., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1410489 · Cited by 4,487
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Self-citation
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J. J., Gotto, A. M., Kastelein, J. J. P., Köenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641
Self-citation
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
Self-citation

Flagged first, then by citations

Show all 64 references

Sorted by citations

Items 301–400 of 417

Inflammation and heart failure risk in atrial fibrillation: Prospective evidence from UK Biobank
Li, L., Wu, L., Hu, Z., Hu, Z., Liu, L., Zhou, L., Peng, X., Xu, M., Zhang, T., Yulong, X., et al. (2025) · Heart Rhythm · doi:10.1016/j.hrthm.2025.11.014 · Cited by 1
Impact of life's essential eight and inflammatory markers on long-term cardiovascular disease risk and all-cause mortality: Insights from the Heart SCORE study
Claudia Bambs, S., Pollack, I. F., Swanson, J., Duan, J., McKennan, C. G., Kip, K. E., Buysse, D., Reís, S. E., & Saeed, A. (2026) · Heart & Lung · doi:10.1016/j.hrtlng.2025.102710 · Cited by 1
Grief or Relief? Dyadic loneliness and biological health after mid-to-late life widowhood
Stokes, J. E., Jessee, L., & Farmer, H. R. (2026) · Biological Psychology · doi:10.1016/j.biopsycho.2026.109208 · Cited by 1
Association of leukocyte mitochondrial DNA copy number and inflammation with mortality among older adults
Wu, I., Liu, C.-S., Cheng, W.-L., Lin, T., & Chen, P. (2026) · Communications Medicine · doi:10.1038/s43856-026-01531-8 · Cited by 1
Association of systemic inflammation with major adverse cardiovascular events in patients with acute myocardial infarction
Nguyen, C., Ackermann, A. M., Marieb, E., Skaar, J. R., Chow, W., Ryali, R., Popadic, L., Wu, X., Ma, X., & Kearney, K. E. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101574 · Cited by 1
Prevalence and characteristics of adults with atherosclerotic cardiovascular disease, chronic kidney disease, and systemic inflammation in the USA
Nanna, M. G., Sloan, L. A., Návar, A. M., Faurby, M. D., Husemoen, L. L. N., Paul, R., Tombak, G., & Sattar, N. A. (2026) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2026.100772 · Cited by 1
Evaluation of HS-CRP in patients with polycystic ovaries and insulin resistance
Hussein, Z. E., Mohammed, R. J., & Wahid, H. H. A. (2026) · AIP conference proceedings · doi:10.1063/5.0319550 · Cited by 1
Systemic Inflammation and Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease and Chronic Kidney Disease
Sandhu, A. T., Furst, A., Rodríguez, F., Kalwani, N. M., Maron, D. J., Nallamshetty, S., Din, N., Zitko, K., Khachatourian, K. W., Skaar, J. R., et al. (2026) · JACC Advances · doi:10.1016/j.jacadv.2026.102765 · Cited by 1
C-reactive protein and mortality in 'SMuRF-less but inflamed' women and men: Evidence from the United Kingdom Biobank
Kahles, F., Kurt, B., Reugels, M., Schneider, K. M., Marx, N., Schneider, C. V., & Ridker, P. M. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101715 · Cited by 1
Self-citation
ApoB-specific CD4+ T cells in atherosclerosis: MHC-II antigen presentation, T cell plasticity, and immune tolerance
Cao, X., Mu, C., & Xu, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1903006 · Cited by 1
Editor-in-Chief’s Top Picks From 2015: Part One
Fuster, V. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.12.002 · Cited by 1
Ability of adiposity indicators to identify elevated high-sensitivity C-reactive protein in young adults
Cabral, M., Severo, M., & Ramos, E. (2018) · Nutrition · doi:10.1016/j.nut.2018.11.025 · Cited by 1
Prevention of Non-Cardiogenic Ischemic Stroke: Towards Personalized Stroke Care
Molnár, T., & Csécsei, P. (2021) · Exon Publications eBooks · doi:10.36255/exonpublications.stroke.personalizedcare.2021 · Cited by 1
Inflammation and Cardiovascular Outcomes
Satish, P., & Agarwala, A. (2024) · Contemporary cardiology · doi:10.1007/978-3-031-54960-1_10 · Cited by 1
PRIMARY PREVENTION OF CARDIOVASCULAR DISEASES AND WAYS OF IMPROVING RISK ASSESSMENT OF THEIR DEVELOPMENT IN CLINICAL PRACTICE
Onyshchenko, O. V., Koshelia, I. I., Riabenko, D. V., & Yepanchintseva, O. A. (2024) · Clinical and Preventive Medicine · doi:10.31612/2616-4868.6.2024.17 · Cited by 4
Cardio-rheumatology: present and future. Part I
Ma, Y., Wang, Z., Vi, M., Trofimov, E. A., & Bashkinov, R. A. (2024) · HERALD of North-Western State Medical University named after I I Mechnikov · doi:10.17816/mechnikov634480 · Cited by 1
Lifetime Exposure to Violence and Early Cardiometabolic Risk Factors in a Healthy Swedish Cohort
Lynch, R., Aspelund, T., Fang, F., Bergstedt, J., Hauksdóttir, A., Arnberg, F. K., Hrafnkelsdóttir, Þ. J., Pedersen, N. L., & Valdimarsdóttir, U. A. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.123.032827 · Cited by 1
Systemic inflammation and Viral Exposure among Young Mexican American Women: Nativity-Related Differences
Rosenberg, N., Daviglus, M. L., DeVon, H. A., Park, C. G., & Eldeirawi, K. M. (2017) · Ethnicity & Disease · doi:10.18865/ed.27.2.133 · Cited by 1
Effects of Pubertal Status and Inflammation on the Use of Ferritin to Define Iron Deficiency in Children With Overweight or Obesity
Muzzio, M. L., Chiappe, E. L., Kabakian, L., Ferraro, F., Landó, I., Alonso, E., Fernández, J., Peredo, S., Brovarone, L., Santucci, M. P., et al. (2019) · Nutrition and Metabolic Insights · doi:10.1177/1178638819839064 · Cited by 1
Sedimantasyon & CRP - Geçmişten Geleceğe
ÇAYAKAR, A. (2019) · Ege Tıp Bilimleri Dergisi · doi:10.33713/egetbd.548235 · Cited by 1
Dysbiosis, Small Intestinal Bacterial Overgrowth, and Chronic Diseases
Silva, A. R., Bernardo, A., de Mesquita, M. F., Patto, J. V., Moreira, P. A. M., Padrão, P., & Silva, M. L. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-4808-0.ch015 · Cited by 1
C-Reactive Protein and Other Inflammatory Markers in Cardiovascular Disease: Inflammatory Disorders and Atherosclerosis
Brandt, E. J. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56514-5_30 · Cited by 1
Biomarker-associated Monocyte Inflammatory Signaling in Myocardial Infarction
Guimarães, R. B., Marchini, J. F. M., Gómez, L. M. G., Leite, R. S., Dutra, Ó. P., Castro, I., & Manica, A. (2023) · International Journal of Cardiovascular Sciences · doi:10.36660/ijcs.20220007 · Cited by 1
Anti-inflammatory Therapy for Cardiovascular Disease
Ridker, P. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88286-6.00024-8 · Cited by 1
Self-citation
High-Sensitivity C-Reactive Protein
David I. Feldman, Blumenthal, R. S., & Gluckman, T. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88286-6.00008-x · Cited by 1
Disarming the Sword of Damocles: Biomarkers and Susceptibilities to Spike Protein DiseasesPreprint
Halma, M. T. J. (2023) · Preprints.org · doi:10.20944/preprints202307.0840.v2 · Cited by 1
Cachexia in Clinical Practice: Experience from an Endocrine-Led Care ModelPreprint
Murthy, A., Simons, M., Jablonski, A., Hurd, M. A., Shukla, A. P., & Goncalves, M. D. (2025) · medRxiv · doi:10.1101/2025.07.09.25331020 · Cited by 1
Assessment of Cardiovascular Risk Beyond Lipid Panel in Cardio-Oncology Patients
Wei, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803547-4.00016-1
Obesity and Its Influence on Mediators of Inflammation: Clinical Relevance of C-Reactive Protein in Obese Subjects
González‐Jiménez, E. (2017) · InTech eBooks · doi:10.5772/64881
Editorial Predictive ability of C-reactive protein for stroke
Ahangar, A. A. (2016)
Evaluation of Cardiovascular Risk Factors in a Young Adults Tunisian Group
Lamine, O., Aboulkacem, S., Grira, N., Ayoub, M., Sendesni, R., Oudi, M. E., Stambouli, N., Chakib, M., & Aouni, Z. (2018) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2018.63001
CME-Labor 54/Auflösung: Entzündungparameter
Annema, W. (2018) · Praxis · doi:10.1024/1661-8157/a002978
Cognitive Decline in Elderly Patients with Hypertensive Heart Disease
Liguori, I., Curcio, F., Abete, P., & Testa, G. (2019) · Springer eBooks · doi:10.1007/978-3-319-90305-7_8-1
Inflammation and Atherosclerotic Cardiovascular Disease
Toth, P. P. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56279-3_14
A Study on the Effect of EECP on Clinical and Echocardiographic Profile of Patients with Angina and Heart Failure
Hasan, V. M. I. (2019)
Association of high sensitivity C-reactive protein and metabolic syndrome components in middle-aged subjects without overt cardiovascular disease in LitHiR primary prevention programme
Saulė, I. M., Mikolaitytė, J., Badarienė, J., Zupkauskienė, J., Puronaitė, R., Čypienė, A., & Laucevičius, A. (2020) · Seminars in Cardiovascular Medicine · doi:10.2478/semcard-2020-0003
ROLE OF HS-CRP AND IRISIN IN OBESITY AND TYPE II DIABETES MELLITUS
Kambale, P. R., Lambe, S. D., & Lambe, K. (2021) · GLOBAL JOURNAL FOR RESEARCH ANALYSIS · doi:10.36106/gjra/0304232
Editor-in-Chief’s Top Picks From 2016: Part One
Fuster, V. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.01.004
The Systemic Inflammation Effect on the Ischemic Stroke Severity and Outcomes in Persons Aged from 18 to 45 Years
Сидорович, Э. К., Лихачев, С. А., Астапенко, А. В., Витковский, Ф. А., Павловская, Т. С., & Севостей, И. Д. (2021) · Неврология и нейрохирургия Восточная Европа · doi:10.34883/pi.2020.10.4.037
Night fasting as an alternative to improve nutritional support and glycaemic control in hospitalised patients with exclusive enteral nutrition
Golin, A., de Jesus, S. R., Alves, B. P., Schott, M., Marques, A. R., dos Santos, L. D., Fleck, J. M. C., da Rocha, J. B. T., & Colpo, E. (2022) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2022.03.007
Inorganic Complexes and Metal-Based for Biomarkers Sensors
Carvalho, C. L. C., Soares, A. M. B. F., Alves, J. R. D. S., Rodrigues, G. D. A., Furtado, N. J. S., dos Santos, G. P., & Magalhães, J. L. (2022) · Springer eBooks · doi:10.1007/978-3-031-10832-7_4
HbA1c and FIB-4 as serologic markers for the risk of progression of stage A heart failure
Grigg, W. S., Mahfooz, F., Chaudhary, D., Zapata, I., & Duffee, D. (2021) · Global Cardiology Science and Practice · doi:10.21542/gcsp.2021.25
Cellular heterogeneity and clonal hematopoiesis of immune system cells in atherosclerosis
Слепцов, А. А. (2022) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2022-5228
Identification of risk indicators for periodontitis: Machine Learning and Feature Importance Analysis (Preprint)Preprint
Park, H. (2022) · doi:10.2196/preprints.44424
Echocardiographic and hemodynamic changes in patients with high-grade varicocele
Ergani, B., Eyiol, A., Karabıçak, M., Gitmez, M., & Körez, M. K. (2023) · Biomolecules and Biomedicine · doi:10.17305/bb.2022.8854
Personalised and patient-centred diabetes care
den Ouden, H. (2023) · doi:10.33540/1762
Night fasting as an alternative to improve nutritional support and glycaemic control in hospitalised patients with exclusive enteral nutrition
Golin, A., de Jesus, S. R., Alves, B. P., Schott, M., Marques, A. R., dos Santos, L. D., Fleck, J. M. C., da Rocha, J. B. T., & Colpo, E. (2023) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2023.05.013
Towards Rigorous Diagnostics for Vaccine InjuryPreprint
Halma, M. T. J. (2023) · Preprints.org · doi:10.20944/preprints202307.0840.v1
Low-grade inflammation in the prognosis of patients undergoing coronary artery bypass grafting: the value of neutrophil-to-lymphocyte ratio (NLR) and growth differentiation factor 15 (GDF15)Preprint
Анатольевна, Г. А., Андреевна, К. Е., Tukish, O. V., & Репин, А. Н. (2023) · Research Square · doi:10.21203/rs.3.rs-3397585/v1
Soluble urokinase plasminogen activator receptor (suRAR) levels: underscoring the link between low educational attainment and death among coronary artery disease patients
Coelho‐Filho, O. R., & Santos, R. D. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad346
Association Between High-Sensitivity C-Reactive Protein and Metabolic Syndrome Among Hispanic/Latino Participants of the Hispanic Community Health Study/Study of Latinos
Mesa, R. A., Damas, O. M., Schneiderman, N., Palacio, A. M., Gallo, L. C., Talavera, G. A., Sotres‐Alvarez, D., Daviglus, M. L., Pirzada, A., Llabre, M. M., et al. (2024) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2023.0298
Emerging Cardiovascular Risk Factors
Demeter, S. H., Papp, P., & Weidner, C. (2024) · Springer eBooks · doi:10.1007/978-3-031-53705-9_8
Predicting risk indicators for periodontitis in a Korean population: Machine learning algorithms approach (Preprint)Preprint
Park, H., Lee, Y.-R., Che, X., & Kim, J.-M. (2024) · doi:10.2196/preprints.63621
Highlighting the Need for Comprehensive Cardiovascular Risk Assessment: Case Report
Mewborn, E., & Swanson, A. P. (2024) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2024.105282
THE CLINICAL RELEVANCE OF INTERLEUKIN 6 & hs-CRP IN CARDIOVASCULAR DISEASES: A CASE STUDY.
Kumar, R., Kumar, R., Shilpa, S., Kumar, S., Kumar, S. T., Muni, S., & Kumari, N. (2025) · Student s Journal of Health Research Africa · doi:10.51168/sjhrafrica.v6i3.1645
Impact of Life’s Essential Eight and Inflammatory Markers on Long-term Cardiovascular Disease Risk and All-cause Mortality: The Heart SCORE StudyPreprint
Claudia Bambs, S., Pollack, I., Swanson, J., Duan, J., McKennan, C. G., Kip, K. E., Buysse, D. J., Reís, S. E., & Saeed, A. (2025) · medRxiv · doi:10.1101/2025.06.02.25328831
Left Ventricular Changes and Inflammatory Biomarkers in HIV-Exposed Uninfected Infants in Jos, Northcentral Nigeria
Ige, O., Adah, R., Chang, C. A., Chaplin, B., Bode-Thomas, F., Sagay, A. S., Mansmann, U., Haas, N. A., & Kanki, P. J. (2025) · Pediatric Cardiology · doi:10.1007/s00246-025-03925-2
Risk Factor Analysis and Predictive Nomogram for Heart Valve Calcification in Rheumatoid Arthritis
Lu, Y., Zhao, X., He, X., Li, M., Xie, Q., & Shuai, S. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm38668
Thrombopoiesis Meets Metabolism—But Not in the CBC: Survey-Weighted Analysis of Platelet Counts, hs-CRP, and Metabolic RiskPreprint
Hemade, A., & Salameh, P. (2025) · Research Square · doi:10.21203/rs.3.rs-7925686/v1
Natural-cause mortality and C-reactive protein levels in patients with schizophrenia spectrum disorders: A prospective total cohort study
Fathian, F., Divkovic, I., Strømme, M. F., Mykletun, A., Kroken, R. A., Bartz-Johannessen, C. A., & Johnsen, E. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.101133
Association between Paleolithic diet fraction and systemic low-grade chronic inflammation in the Malmö diet and cancer study cohort
Carrera‐Bastos, P., Rydhög, B., Granfeldt, Y. E., Sundquist, K., Sonestedt, E., Nilsson, P. M., & Jönsson, T. (2025) · European Journal of Nutrition · doi:10.1007/s00394-025-03838-z
The hemopexin-apolipoprotein B product: a novel biomarker integrating oxidative stress and lipid metabolism for coronary artery disease risk stratification
Jin, Y., Chen, K., & Fan, Q.-X. (2025) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2025.111043
TNF-α-Driven Systemic Inflammasome Hyperactivity Links Psoriatic Inflammation to monocyte inflammatory response and platelet activationPreprint
Verma, D., Jeppsson, F., Sjögren, F., Andersson, B., Bivik, C. A., Kasic, N.-K., Moparthi, L., & Enerbäck, C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.24.690330
Additional file 3 of Complement component 7 is associated with total- and cardiac death in chest-pain patients with suspected acute coronary syndrome
Aarsetoey, R., Ueland, T., Aukrust, P., Michelsen, A. E., Leon de la Fuente, R., Grundt, H., Staines, H., Nygaard, O. K., & Nilsen, D. W. T. (2021) · Figshare · doi:10.6084/m9.figshare.16815770
Additional file 1 of C-reactive protein in traditional melanesians on Kitava
Carrera-Bastos, P., Fontes‐Villalba, M., Gurven, M., Muskiet, F. A. J., Åkerfeldt, T., Lindblad, U., Råstam, L., Frostegård, J., Shapira, Y., Shoenfeld, Y., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13467361
Additional file 1 of Supra-additive effect of chronic inflammation and atherogenic dyslipidemia on developing type 2 diabetes among young adults: a prospective cohort study
Lan, Y., Wu, D., Cai, Z., Xu, Y., Ding, X., Wu, W., Lan, S., Chen, L., Guo, Z., Balmer, L. A., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23691216
Additional file 1 of Measurement of cumulative high-sensitivity C-reactive protein and monocyte to high-density lipoprotein ratio in the risk prediction of type 2 diabetes: a prospective cohort study
Wu, D., Chen, G., Lan, Y., Chen, S., Ding, X., Wei, C., Balmer, L. A., Wang, W., Wu, S., & Xu, W. (2024) · Figshare · doi:10.6084/m9.figshare.25101097
Additional file 1 of Temporal relationship between atherogenic dyslipidemia and inflammation and their joint cumulative effect on type 2 diabetes onset: a longitudinal cohort study
Lan, Y., Chen, G., Wu, D., Ding, X., Huang, Z., Wang, X., Balmer, L. A., Li, X., Song, M., Wang, W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22600996
Additional file 1 of Rivaroxaban in patients with abdominal aortic aneurysm and high-sensitivity C-reactive protein elevation (BANBOO): study protocol for a randomized, controlled trial
Li, J., Ma, S., Jia, X. J., Bu, Y., Zhou, T., Zhang, L., Qiu, M., & Wang, X. (2023) · Figshare · doi:10.6084/m9.figshare.23542921
Additional file 1 of Combined effect of adiposity and elevated inflammation on incident type 2 diabetes: a prospective cohort study
Wu, D., Lan, Y., Chen, S., Ding, X., Chen, G., Wu, C., Balmer, L. A., Xu, W., Wu, S., & Wang, W. (2024) · Figshare · doi:10.6084/m9.figshare.26657131
Additional file 1 of Prognostic value of fibrosis-5 index combined with C-reactive protein in patients with acute decompensated heart failure
Wang, Z., Li, G., Huang, R., Chang, L., Gong, C., Chen, K., & Wang, L. (2023) · Figshare · doi:10.6084/m9.figshare.24248047
Additional file 1 of Impact of semaglutide on high-sensitivity C-reactive protein: exploratory patient-level analyses of SUSTAIN and PIONEER randomized clinical trials
Mosenzon, O., Capehorn, M. S., Remigis, A. D., Rasmussen, S., Weimers, P., & Rosenstock, J. (2022) · Figshare · doi:10.6084/m9.figshare.20882123
Formulation and Evaluation of Rosuvastatin Calcium Liposomal Mucoadhesive Buccal Film
Halasagi, V., Dandagi, P. M., & Anusha, M. (2025) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-025-10294-z
C‑reactive protein as a prognostic factor for coronary artery bypass graft failure and unfavourable myocardial revascularization outcomes
Buziashvili, Y. I., Кокшенева, И. В., Matskeplishvili, S. T., Уметовна, А. Э., Ирасханов, А. Ш., Golubev, E. P., Ibragimov, R. M., Тугеева, Э. Ф., Иошина, В. И., Temirbulatova, T. R., et al. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6108
Time-dependent associations between early high-sensitivity C-reactive protein levels and post-traumatic stress disorder after physical injury
Kim, J., Kang, H.-J., Kim, J.-W., Lee, J.-Y., Jang, H., Kim, J.-C., Kim, S.-W., & Shin, I.-S. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.117005
Clinical Knowns and Mechanistic Unknowns: Cardioprotection and Inflammation Modulation of GLP-1 Receptor Agonists and SGLT2 Inhibitors
Kim, E. Y., & Feinstein, M. J. (2026) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2026.02.024 · Cited by 1
Extracardiac Thoracoabdominal Atherosclerosis in Heart Transplant Candidates is not Associated with Standard Modifiable Cardiovascular Risk FactorsPreprint
Readford, T. R., Ugander, M., Kench, P. L., Hayward, C., Figtree, G. A., Nadel, J., & Giannotti, N. (2026) · medRxiv · doi:10.64898/2026.02.25.26347056
Targeting Vascular Inflammation In Patients with Community-Acquired Pneumonia (TIN-CAP): protocol for a multicentre, randomised, double-blind, placebo-controlled trial
Stotts, C., Corrales‐Medina, V., deKemp, R. A., Wells, G. A., Beanlands, R. S., Raggi, P., Ferrara, G., Sligl, W., Connelly, K. A., Paul, N. S., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-114239
Vitamin D status as a moderator of inflammation-mediated associations between adiposity and major adverse cardiovascular events: a cohort-based moderated mediation analysis
Bennouar, S., Cherif, A. B., Aoudia, Y., FISSAH, M., & Abdi, S. (2026) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2026.104700
The predictive value of the C-reactive protein-stress hyperglycemia ratio for in-hospital major adverse cardiovascular events in patients with ST-segment elevation myocardial infarction
Hou, X., Zhou, X., Wang, W., Chen, X., Li, Y., Gong, Z., Yang, Y., & Zhang, X. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1703043
Inflammation in Patients With Obstructive Sleep Apnea Undergoing Percutaneous Coronary Intervention
Pitaro, N. L., Zhang, V., Sartori, S., Smith, K. F., Oliva, A., Procopi, N., Kini, A. S., Dangas, G., Sharma, S. K., & Mehran, R. (2026) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2026.03.045
Different CRP Cutoff Values in East Asian Patients
Abbate, A., Garshick, M. S., & Weber, B. (2026) · JACC Asia · doi:10.1016/j.jacasi.2026.02.010
Cerebrovascular integrity maintenance and inflammation in atherosclerosis animal models
Cataldo, V. D. (2016) · theses.fr (ABES) · doi:10.70675/7b5a6c4bz3377z40fezbf48z5da7afd1a502
Inflammation, aging and chronic diseases : implication of inflammasomes
Guerville, F. (2023) · theses.fr (ABES) · doi:10.70675/eac3286czda71z4606z9c90z3d3efeaf1afe
Quantifying Periodontal Inflammatory Burden: A Conceptual Clinical Framework Integrating Periodontal Inflamed Surface Area (PISA) and High-Sensitivity C-reactive Protein (Hs-CRP) for Oral–Systemic Health
Mascolo, A., Dinculescu, O., Bassignani, J., & Bensaidi, S. (2026) · Cureus · doi:10.7759/cureus.106798
Admission C-Reactive Protein and Mortality After STEMI: A Retrospective Cohort Study Identifying Subgroup-Specific Risk Thresholds
Kopp, K. L., Leitner, M., Clodi, N., Lichtenauer, M., Hammerer, M., Hoppe, U. C., Boxhammer, E., & Brandt, M. C. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15082864
Diet Quality and Advanced Periodontitis in Relation to Serum CRP Levels: An 11‐Year Follow‐Up Study
Syrjäläinen, S., Männistö, S., Könönen, E., Suominen, A. L., & Gürsoy, U. K. (2026) · Food Science & Nutrition · doi:10.1002/fsn3.71762
Inflammatory biomarkers relationship with major adverse cardiovascular events and hypertensive-mediated organ damage, in subjects without established cardiovascular disease
Tognola, C., Bernasconi, D. P., Rebora, P., Intravaia, R. C. M., Mancusi, C., Visco, V., Cesaro, A., Golia, E., Fucile, I., Merlini, P., et al. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101640
Real-world impact of oral semaglutide on inflammatory markers in patients at high cardiovascular risk
Vázquez, S. M., Jiménez-Méndez, C., Asensio, A. P., Silva, E., Delgado, P. R., Fernández, L. G., Concellón, M. D. R. B., de la Mano, J. A. P., Vital, A. G., & Pérez, G. C. (2026) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2026.502562
Sex-specific associations of the triglyceride-glucose index with systemic inflammation and arterial stiffness in adults with normal glucose and triglyceride levels
Shen, W.-C., Chen, H., Wu, I.-H., Su, F.-L., Lee, W.-H., Tai, J.-T., Chou, Y.-T., & Chan, S. (2026) · Atherosclerosis Plus · doi:10.1016/j.athplu.2026.100565
Impacto de la semaglutida oral sobre los marcadores inflamatorios en los pacientes de alto riesgo cardiovascular en vida real
Vázquez, S. M., Jiménez-Méndez, C., Asensio, A. P., Silva, E., Delgado, P. R., Fernández, L. G., Concellón, M. D. R. B., de la Mano, J. A. P., Vital, A. G., & Pérez, G. C. (2026) · Revista Clínica Española · doi:10.1016/j.rce.2026.502562
Longitudinal analysis of cytokines, chemokines, and inflammatory markers in a middle-aged cohort
Hooten, N. N., Mode, N. A., Ezike, N., Zonderman, A. B., & Evans, M. K. (2026) · GeroScience · doi:10.1007/s11357-026-02318-4
Comparing clinical manifestations, treatment strategies and outcomes of Staphylococcus lugdunensis bacteraemia versus Staphylococcus aureus bacteraemia – a retrospective cohort study
Webb, G., Choi, J., Younes, A., Schembri, E., Chean, R., & Guy, S. (2026) · Internal Medicine Journal · doi:10.1111/imj.70481
Combined Association of Serum Uric Acid and High-Sensitivity C-Reactive Protein with Chronic Kidney Disease: A Nationwide Cross-sectional Population-based StudyPreprint
Choi, S.-S., Ko, S., Lee, K. N., Han, K., Kim, H. W., Lee, J., Park, H., & Kim, H. (2026) · Research Square · doi:10.21203/rs.3.rs-9658917/v1
Cardiometabolic Risk Factors, Inflammation, and Endothelial Dysfunction in Primary Antiphospholipid Syndrome (PAPS)Preprint
Baleeiro, C., & Júnior, D. A. (2026) · Research Square · doi:10.21203/rs.3.rs-9379154/v1
Beyond traditional risk factors: the impact of cumulative inflammation and remnant cholesterol on myocardial infarction in a prospective cohort study
Zhou, K., Liu, G., Zhang, B., Zhang, X., Wu, W., & Wu, S. L. (2026) · Lipids in Health and Disease · doi:10.1186/s12944-026-02992-5
In-bedroom renewed air as anti-inflammatory adjuvant therapy in cancer survivors: protocol for the randomised, placebo-controlled BREATHS N-of-1 trial series
Hernandez-Garcia, E., Edkins, A., Chrysikou, E. G., Ordóñez-Mena, J. M., Nekhlyudov, L., Kim, J. B., McLean, G. R., Frost, H., & Panigrahy, D. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-111748
Inflammation and the Heart: The Role of Traditional Factors
Cheraghi, M., Amin, A., Jabarzare, S., Sabooteh, T., Moradi, P., Dehghani, M., Sedighi, M., Hatami, F., Rafieian, A., & Farshidfar, T. (2026) · Cardiology Research and Practice · doi:10.1155/crp/4623305
Real-World Analysis of the Association Between Systemic Inflammation, Cardiovascular Events, and Economic Burden Among Patients with Atherosclerotic Cardiovascular Disease and Chronic Kidney Disease
Nguyen, C., Ryali, R., Skaar, J. R., Chow, W., Robar, C., Kaufman, A., Li, W., & Shah, B. (2026) · Cardiology and Therapy · doi:10.1007/s40119-026-00459-3
Predictive value of C-reactive protein for progression from prehypertension to hypertension: a prospective cohort study based on the CHARLS database
Fan, Y., Zhang, C., Qian, Y., Zhu, Z., Tian, X., Cui, X., Wang, M., Wang, D., & Xue, G. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-06375-7

Authors: Ridker, P. M.
Affiliations: Brigham and Women's Hospital (US)
Corresponding author: Ridker, Paul M
ORCID: Ridker, Paul M
Venue: Journal of the American College of Cardiology
Publisher: Elsevier BV
Published: 2016-02
Volume: 67
Issue: 6
Pages: 712-723
ISSN: 0735-1097 (ISSN-L)
DOI: 10.1016/j.jacc.2015.11.037
OpenAlex: W2264523161
Cited by: 414
References: 64
Citations by year: 2026: 54 · 2025: 51 · 2024: 45 · 2023: 47 · 2022: 35 · 2021: 35 · 2020: 48 · 2019: 34 · 2018: 30 · 2017: 19 · 2016: 16
FWCI: 6.54
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 381 d)
Locations: Journal of the American College of Cardiology (publishedVersion)
PubMed (publishedVersion)
Funders: Pfizer
AstraZeneca
American College of Cardiology Foundation
National Heart, Lung, and Blood Institute (U01HL101422)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
Keywords: high-sensitivity C-reactive protein, inflammation, cardiovascular risk, cardiovascular risk prediction, statins, rosuvastatin, JUPITER trial, primary prevention, Framingham risk factors, LDL cholesterol, myocardial infarction, stroke, cardiovascular mortality
MeSH terms: C-Reactive Protein, Cardiovascular Diseases, Humans, Predictive Value of Tests, Global Health, Reproducibility of Results, Biomarkers, Incidence, Survival Rate, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A Test in Context

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks